e-learning
resources
Munich 2014
Monday, 08.09.2014
Tuberculosis: from epidemiology to therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The absolute values of extravascular lung water content as a criterion in the evaluation of the functional operability of patients with progressive pulmonary tuberculosis
M. G. Kovalev, P. K. Yablonsky (St. Petersburg, Russian Federation)
Source:
International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Session:
Tuberculosis: from epidemiology to therapy 2
Session type:
Thematic Poster Session
Number:
2671
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. G. Kovalev, P. K. Yablonsky (St. Petersburg, Russian Federation). The absolute values of extravascular lung water content as a criterion in the evaluation of the functional operability of patients with progressive pulmonary tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2671
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Changes in pulmonary function in patients with lung tuberculoma
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Preoperative functional status in patients with lung tuberculosis before pneumonectomy
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Lung function in patients cured for pulmonary tuberculosis
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Pulmonary function following treatment for pulmonary tuberculosis
Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Year: 2006
Radiologic profile of treated pulmonary tuberculosis patients and their correlation with modified medical research council scale and spirometry
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Medical and social criteria of effectiveness of lung resections in pulmonary tuberculosis (TB)
Source: Eur Respir J 2007; 30: Suppl. 51, 199s
Year: 2007
A trial of the measurement of dynamic lung compliance by the new method using photoplethysmography in patients with COPD and pulmonary fibrosis
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Prediction of complications after pneumonectomy in patients with pulmonary tuberculosis
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Advance lung function testing: Lung Volumes(TLC) & Diffusing Capacity(DLco) diagnoses substantial pulmonary function impairment in treated Pulmonary Tuberculosis patients
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Emphysema distribution determines distinct pulmonary function features
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Scintigraphic parameters in COPD patients
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Usefulness of respiratory impedance by measuring at functional residual capacity position
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Airspace dimension test (ADT): A novel technique for diagnosis of the peripheral lung
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Determination of total lung capacity (TLC) without body plethysmography
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept